Correlation between Platelets Count and C-reactive Protein in COVID-19 Patient in Jember Regency
DOI:
https://doi.org/10.24293/ijcpml.v29i2.2002Keywords:
COVID-19, laboratory, biomarkers, platelets, CRPAbstract
The laboratory test for Coronavirus disease 2019 (COVID-19) is very important for initial treatment and predicting the prognosis of the patients, but there have been reports of false negative COVID-19 diagnostic test results. Another study reported changes in COVID-19 patient biomarkers, namely platelets count and C-Reactive Protein (CRP) levels. This study investigated the correlation between platelet count and CRP in COVID-19 patients. This study was conducted using a cross-sectional analytic observational method, through secondary data analysis of COVID-19 patients who hospitalized between June – August 2021 at Dr. Soebandi Hospital and Jember Klinik Hospital. Of 30 patients, there were 16 male patients (53%) and 14 female patients (47%); 18 patients in the 46-59 years old age group (60%) and 12 patients in ≤ 4 years old (40%) age group; and there were 8 patients admitted to ICU (26.67%). There was a negative correlation between platelet count and CRP in COVID-19 patients (r = -0.733; p<0.001). A strong correlation between platelet count and CRP is related to prognostic and predictive factors of severity in COVID-19 patients. Further studies about the analysis of other biomarkers in COVID-19 are needed to obtain more prognostic and predictive factors of severity in patient.
Downloads
References
Yüce M, E. Filiztekin, ¨Ozkaya KG. COVID-19 diagnosis-A review of current methods. Biosens Bioelectron J. 2020; 172: 112752.
Kemenkes RI. Situasi terkini perkembangan Coronavirus Disease (COVID-19). 2022. Available from https://infeksiemerging.kemkes.go.id/document/situasi-terkini-perkembangan-coronavirus-disease-covid-19-17-juli-2022.pdf (accessed July 20, 2022).
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, et al. Hematological findings and complications of COVID-19. Am. J. Hematol, 2020; 95(7): 834–847.
Pfoh ER, Hariri EH, Misra-Hebert AD, Deshpande A, Jehi L, Rothberg MB. Late Diagnosis of COVID-19 in Patients Admitted to the hospital. J. Gen. Intern. Med, 2020; 35(9): 2829–2831.
Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol, 2020; 92(11): 2409–2411.
Mei H, Luo L, Hu Y. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. J. Hematol. Oncol, 2020; 13(1): 13–15.
Ziegler M, Wang X, Peter K. Platelets in cardiac ischaemia/reperfusion injury: A promising therapeutic target. Cardiovasc. Res, 2019; 115(7): 1178–1188.
Suryana D, Widaningsih Y, Mangarengi F, Muhadi D. Analysis of Platelet indices and proteinuria in primary hypertensive patients. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2022; 28(2): 105–110.
Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol, 2021; 113(1): 45–57.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol, 2018; 9: 1-11.
Bayram M, Yildrim O, Ozmen RS, Soylu B, Dundar AS, et al. Prognostic nutritional index and crp, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19. Biomark. Med, 2021; 15(18): 1733–1740.
Francesca C, Luca C, Laura C, Flavia M, Mario R. The cytokine storm in COVID-19: An over view of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev, 2020; 53: 25–32.
Widjaja JT, Kwee L, Giantara AK, Subagiyo HA, Edwin C, Putri RL. Karakteristik pasien COVID-19 rawat inap di RS Immanuel Bandung, Indonesia. J. Med Heal, 2021; 3(2): 164–175.
Maryati W, Widyastuti A, Pinta A, Rizky K, Ika P, Aryanti FD. Analisis karakteristik pada pasien rawat inap kasus COVID-19. INFOKES, 2022; 12(1): 20–25.
Raza HA, Sen P, Bhatti OA, Gupta L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol. Int, 2021; 41(8): 1375–1386.
Ernawati A. Overview of COVID-19 cases by gender, age group, and population density in Pati regency. Jurnal Litbang, 2021; 17(2): 131–146.
Zeng JH, Wu WB, Qu JX, Wang Y, Dong CF, et al. Cardiac manifestations of COVID-19 in Shenzhen, China. Infection, 2020; 48(6): 861–870.
Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazetti C, et al. Compassionate remdesivir treatment of severe COVID- pneumonia in Intensive Care Unit (ICU) and non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.Pharmacological Research, 2020; 158: 104899.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 2020; 395(0223): 507–513.
Gowda SB, Gosavi S, Rao AA, Shastry S. Prognosis of COVID-19: Red cell distribution width, platelet distribution width, and C-reactive protein. Cureus; 2021; 13(2): e13078.
Melnikov IS, Kozlov SG, Saburova OS, Avtaeva NY, Prokofieva LV, Gabbasov ZA. Current position on the role of monomeric C-reactive protein in vascular pathology and atherothrombosis. Current Pharmaceutical Design, 2020; 1–7.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
